Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy Against
Waldenström's Macroglobulinemia.

I Kuiatse; V Baladandayuthapani; H Lin; S Thomas; C Bjorklund; D Weber; M Wang; J Shah; X Zhang; R Jones; S Ansell; G YANG; R ORLOWSKI

Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy Against Waldenström's Macroglobulinemia.

I Kuiatse, V Baladandayuthapani, H Lin, S Thomas, C Bjorklund, D Weber, M Wang, J Shah, X Zhang, R Jones, S Ansell, G YANG, R ORLOWSKI

Pediatrics

Research output: Contribution to journal › Article

Original language	English (US)
Journal	Clinical Cancer Research.
Volume	21(11):2538-45
State	Published - Jan 1 2015

Cite this

@article{3cecff1e485145ef81c6c5402940b351,

title = "Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy Against Waldenstr{\"o}m's Macroglobulinemia.",

author = "I Kuiatse and V Baladandayuthapani and H Lin and S Thomas and C Bjorklund and D Weber and M Wang and J Shah and X Zhang and R Jones and S Ansell and G YANG and R ORLOWSKI",

year = "2015",

month = jan,

day = "1",

language = "English (US)",

volume = "21(11):2538-45",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research Inc.",

}

TY - JOUR

T1 - Targeting the Spleen Tyrosine Kinase with Fostamatinib as a Strategy Against Waldenström's Macroglobulinemia.

AU - Kuiatse, I

AU - Baladandayuthapani, V

AU - Lin, H

AU - Thomas, S

AU - Bjorklund, C

AU - Weber, D

AU - Wang, M

AU - Shah, J

AU - Zhang, X

AU - Jones, R

AU - Ansell, S

AU - YANG, G

AU - ORLOWSKI, R

PY - 2015/1/1

Y1 - 2015/1/1

M3 - Article

SN - 1078-0432

VL - 21(11):2538-45

JO - Clinical Cancer Research

JF - Clinical Cancer Research

ER -